Altered patterns of MDM2 and TP53 expression in human bladder cancer

Journal of the National Cancer Institute

Volumn 86, Issue 17, 1994, Pages 1325-1330

  Lianes, Pilar ^a   Orlow, Irene ^a   Zhang, Zuo Feng ^a   Oliva, Maria R ^a   Sarkis, Alvaro S ^a   Reuter, Victor E ^a   Cordon cardo, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER STAGING; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DNA CONFORMATION; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

AGED; ANTIBODIES, MONOCLONAL; BLADDER NEOPLASMS; BLOTTING, SOUTHERN; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGE; MUTATION; NEOPLASM PROTEINS; PHENOTYPE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028023524     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/86.17.1325     Document Type: Article

References (49)

1. Silverberg E, Boring C, Squires T: Cancer Statistics 1990. Ca 40:1-8, 1990
2. Mostofi F, Sobin L, Torloni H: Histologic typing of urinary bladder tumors. WHO Monogr 10:1973
3. Gilbert H, Logan J, Kagan A: The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading. J Urol 119:488-492, 1978
4. Augustine A, Herbert JR, Rabat GC, et al.: Bladder cancer in relation to cigarette smoking. Cancer Res 48:4405-4408, 1988
5. Talasaka G, Al-Juburi A, Kadlubar F, et al.: Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder. Proc Natl Acad Sci U S A 88:5350-5354, 1991
6. Furihata M, Inoue K, Ohtsuki Y, et al: Highrisk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 53:4823-4827, 1993
7. Presti JC Jr., Reuter VE, Galan T, et al.: Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51:5405-5409, 1991
8. Cordon-Cardo C, Wartinger D, Petrylak D, et al.: Altered expression of the retinoblastoma gene product is a prognostic indicator in bladder cancer [see comment citation in Medline]. J Natl Cancer Inst 84:1251-1256, 1992
9. Dalbagni G, Presti J, Reuter V, et al.: Genetic alterations in bladder cancer [see comment citation(s) in Medline]. Lancet 342:469-471, 1993
10. Sarkis AS, Dalbagni G, Cordon-Cardo C, et al.: Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 85:5359, 1993
11. Esrig D, Spruck CH, Nichols P, et al.: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer. Am J Pathol143:1389-1397,1993
12. Dalbagni G, Presti J, Reuter V, et al.: Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diag Mol Pathol 2:4-13, 1993
13. Sarkis A, Zhang Z-F, Cordon-Cardo C, et al.: p53 nuclear overexpression and disease progression in Ta bladder carcinoma. Int J Oncol 3:355-360, 1993
14. Yew P, Berk A: Inhibition of p53 transactivation required for transformation by adenovirus early IB protein. Nature 357:82-85, 1992
15. Mietz J, Unger T, Huibregtse J, et al.: The transcriptional transactivation function of wild-type TP53 is inhibited by SV40 large T-antigen and HPV-16 E6 oncoprotein. EMBO J 11:5013-5020, 1992
16. Wetness B, Levine A, Howley P: The E6 proteins encoded by human papillomavirus types 16 and 18 can complex p53 in vitro. Science 248:76-79, 1990
17. Momand J, Zambetti GP, Olson DC, et al.: The mdm-2 oncogene product forms a complex with the p-53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245, 1992
18. Oliner JD, Kinzler KW, Metlzer PS, et al.: Amplification of a gene encoding a p53-as-sociated protein in human sarcomas [see comment citation in Medline], Nature (Lond) 358:80-83,1992
19. Manual for the Staging of Cancer (4th Edition). American Joint Committee on Cancer. TNM Committee of the International Union Against Cancer, 1993
20. Fakharzadeh S, Trusko S, George D: Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J 10:1565-1569, 1991
21. Chen J, Marechal V, Levine AJ: Mapping of the p53 and mdm-2 interaction domain. Mol Cell Biol 13:4107-4114, 1993
22. Banks L, Matlashewski G, Crawford L: Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human TP53 expression. Eur J Biochem 159:529-534, 1986
23. Schawb M, Amler L: Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer. Genes Chromosom Cancer 1:181-185, 1990
24. Orita M, Suzuki Y, Sekiya T, et al.: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879, 1989
25. Moll UM, Riou G, Levine AJ: Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci U S A 89:7262-7266, 1992
26. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74:5463-5467, 1977
27. Mehta C, Patel N: A network algorithm for performing Fisher’s exact test in rXc contingency tables. J Am Stat Assoc 78:427-434, 1983
28. Miyao N, Tsai YC, Lemer SP: Role of chromosome 9 in human bladder cancer. Cancer Res 53:4066-4070, 1993
29. Cairns P, Shaw ME, Knowles MA: Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res 53:1230-1232, 1993
30. Silverman DT, Hartge P, Morrison AS, et al.: Epidemiology of bladder cancer. Hematol Oncol Clin North Am 6:1-30, 1992
31. Bryant P, Skelly J, Wilson D: Demonstration of papillomavirus structural antigen in human urinary bladder neoplasia. Br J Urol 60:405-409,1987
32. Khurshid A, Hironobu N, Kazuya N. et al.: High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 70:1967-1973, 1992
33. Farmer G, Bargonetti J, Zhu H, et al.: Wildtype p53 activates transcription in vitro. Nature 358:83-86. 1992
34. Martinez J, Georgoff I, Martinez J, et al.: Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5:151-159, 1991
35. Kastan MB, Zhan Q, el-Deiry WS: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597, 1992
36. Lowe S, Schmitt E, Schmith S, et al.: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849, 1993
37. Clarke AR, Purdie CÀ, Harrison DJ, et al.: Thymocyte apoptosis induced by p53-depend-ent and independent pathways [see comment citation in Medline]. Nature 362:849-852, 1993
38. Scheffner M, Huibregtse JM, Vierstra RD, et al.: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubi-quitination of p53. Cell 75:495-505, 1993
39. Dittmer D, Sibani P, Zambetti G, et al.: Gain of function mutations in p53. Nature 4:42-45, 1993
40. Zhang W, Funk WD, Wright WE, et al.: Novel DNA binding of p53 mutants and their role in transcriptional activation. Oncogene 8:2555-2559,1993
41. Bargonetti J, Reynisdottir I, Friedman PN, et al.: Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev 7:1988-1998, 1993
42. Wu X, Bayle JH, Olson D, et al.: The p53-mdm-2 autoregulatory feedback loop. Gene Dev 7:1126-1132, 1993
43. Perry ME, Piette J, Zawadzki JA, et al.: The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci U S A 90:11623-11627, 1993
44. Price BD, Park SJ: DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells. Cancer Res 54:896-899, 1994
45. Orlow I, Lianes P, Lacombe L, et al.: Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54: 2848-2851, 1994
46. Ladanyi M, Cha C, Lewis R, et al.: MDM2 gene amplification in metastatic osteosarcoma. Cancer Res 53:16-18, 1993
47. Leach FS, Tokino T, Meltzer P, et al.: p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53:2231-2234,1993
48. Cordon-Cardo C, Latres E, Drobnjak M, et al.: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res (suppl 10)54:794-799, 1994
49. Reifenberger G, Liu L, Ichimura K, et al.: Amplification and overexpression of the MDM2 gene in a subset of human gliomas without p53 mutations. Cancer Res 53:2736-2739,1993